Discovering DMTF1: NUS's Game-Changing Protein for Brain Cell Renewal

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have unveiled a pivotal discovery in the fight against brain aging. The protein cyclin D-binding Myb-like transcription factor 1, commonly abbreviated as DMTF1, has been identified as a key regulator that can restore the regenerative power of neural stem cells (NSCs) in aging brains. Neural stem cells are undifferentiated cells in the adult brain capable of dividing to produce neurons and glial cells, essential for maintaining cognitive functions like learning and memory.

Led by Assistant Professor Ong Sek Tong Derrick from the Department of Physiology and first-authored by Dr. Liang Yajing, the study demonstrates that DMTF1 levels drop significantly in aged NSCs, particularly those affected by telomere shortening—a hallmark of cellular aging where chromosome ends erode over repeated divisions. Remarkably, upregulating DMTF1 revives NSC proliferation without compromising their ability to differentiate into functional brain cells. This finding, detailed in a January 2026 publication in Science Advances, opens doors to novel interventions for age-related cognitive decline.

The Science Behind Aging Brain Cells and NSC Dysfunction

As we age, the brain's ability to generate new neurons diminishes, largely due to NSCs entering a quiescent state or failing to proliferate effectively. Telomere attrition triggers DNA damage responses, including p53 activation, which suppresses cell division to prevent cancer but inadvertently accelerates brain aging. In Singapore, where the population is rapidly greying—with projections estimating one in four residents aged 65 and above by 2030—this poses a pressing public health challenge. Dementia affects about 1 in 10 Singaporeans over 60, with cases expected to rise from 82,000 currently to over 150,000 by 2030, underscoring the urgency for breakthroughs like this NUS study.

Prior research has shown partial restoration of NSC function, but mechanisms were elusive. NUS scientists used telomerase-deficient mouse models (G4 TERT^ER/ER mice) mimicking premature aging, alongside human neural progenitor cells from embryonic stem cells (hESCs). They observed DMTF1 downregulation correlated with reduced markers like MCM2 (a DNA replication protein) and increased apoptosis.

Unpacking the NUS Study's Methodology and Evidence

The NUS team employed a multi-faceted approach: immunofluorescence for NSC markers (Nestin, SOX2), BrdU/EdU labeling for proliferation, Western blots for protein levels, and advanced genomics like ChIP-seq for DMTF1 binding sites. Neurosphere assays quantified self-renewal, while cortical organoids from hESCs tested human relevance. Key evidence showed DMTF1 overexpression in telomere-dysfunctional NSCs rescued BrdU incorporation by 2-3 fold, reduced γH2AX (DNA damage marker), and lowered p53 without telomere restoration.

RNA-seq revealed DMTF1 targets enriched in chromatin remodeling pathways. Luciferase reporters confirmed direct activation of Ss18 promoter. Depleting DMTF1 via CRISPR mimicked aging phenotypes, validating causality. All experiments adhered to NUS Institutional Animal Care guidelines, ensuring ethical rigor.

The Molecular Mechanism: DMTF1's SWI/SNF-E2F Pathway

DMTF1, traditionally linked to cancer suppression via Arf/p53, plays a proliferative role in NSCs. It transcriptionally activates Arid2 and Ss18—core subunits of SWI/SNF chromatin remodeling complexes. These bind E2F1/4 transcription factors at promoters of cell cycle genes (e.g., MCM2, Plk1), depositing H3K27ac (active acetylation mark) while countering repressive H3K27me3.

• Step 1: DMTF1 binds GGCGGCGG motifs in Arid2/Ss18 promoters.
• Step 2: SWI/SNF opens chromatin at E2F targets.
• Step 3: Enhanced E2F activity drives G1/S transition and DNA replication.
• Step 4: Proliferation restored, apoptosis reduced.

ChIP-qPCR confirmed reduced occupancy and H3K27ac upon DMTF1 knockdown. This axis explains why aged NSCs fail to renew.

Implications for Singapore's Super-Aged Society

Singapore's demographic shift amplifies the study's relevance. With dementia prevalence at 8.8% among seniors (down slightly from 10% a decade ago due to better health), cognitive preservation is national priority. NUS's finding aligns with government initiatives like the Healthier SG campaign and National Dementia Plan, targeting brain health through research translation.

Locally, this could spur biotech startups and clinical trials. For academics, it highlights opportunities in research jobs focusing on longevity. NUS Medicine's Healthy Longevity Translational Research Programme (TRP), led by Prof. Brian Kennedy, integrates this work, running trials on exercise-nutrition combos for 50-80 year-olds.

Expert Perspectives and Researcher Insights

"Impaired neural stem cell regeneration has long been associated with neurological ageing... Understanding these mechanisms provides a stronger foundation for studying age-related cognitive decline," states Asst Prof Ong. Dr. Liang adds, "Our findings suggest DMTF1 can contribute to neural stem cell multiplication in neurological aging, guiding therapeutics."

Experts praise the tissue-specific role of DMTF1, contrasting its tumor-suppressive function elsewhere. No major controversies, but calls for in vivo validation. LinkedIn posts by Ong highlight the paper's impact.

Future Directions: From Lab to Longevity Therapies

NUS plans in vivo tests in aged mice and primates to assess neurogenesis, memory via Morris water maze, and tumor safety. Small molecule screens aim to activate DMTF1 safely. Challenges include delivery across blood-brain barrier and off-target effects.

In Singapore's vibrant higher ed ecosystem, this fuels collaborations with A*STAR and Duke-NUS. Aspiring researchers can explore higher ed jobs in neuroscience.

NUS Medicine's Leadership in Ageing Research

NUS ranks globally top for research impact, with Yong Loo Lin School spearheading TRPs. Healthy Longevity TRP advances interventions like senolytics and AI-driven diagnostics. This DMTF1 study exemplifies Singapore's push as a biomedical hub, attracting talent via Singapore academic opportunities.

Broader Impacts on Higher Education and Biotech Careers

This publication boosts NUS's profile, drawing funding and partnerships. For students and profs, it signals demand for neurobiologists—check university jobs or professor jobs. Ethical considerations in stem cell editing align with Singapore's bioethics framework.

Stakeholders: Patients gain hope; policymakers, evidence for R&D investment; industry, IP opportunities.

Photo by Jocelyn Morales on Unsplash

Conclusion: Pioneering Brain Health at NUS

The DMTF1 discovery marks a milestone in reversing brain aging, positioning NUS as a longevity leader. For career advice, visit higher ed career advice; rate faculty at Rate My Professor; seek roles at higher ed jobs or research jobs. Singapore's future looks sharper thanks to such innovations.